Analysis of the Active Pharmaceutical Ingredients Market

Growth Opportunities Abound in Biological APIs

This study covers the active pharmaceutical ingredients (APIs) market for Singapore, Malaysia, Thailand, Philippines, Indonesia, Vietnam, Australia, and New Zealand. The study is segmented according to the customer base and the ingredient’s mode of synthesis. The study details the revenue forecasts and market trends for generic, innovative, synthetic, and biological APIs. The competitive structure is provided, along with a detailed attractiveness index for contract manufacturing of APIs in each of the countries. Furthermore, drivers and restraints influencing the market are discussed, and the revenue split by country and therapeutic areas is included. The base year is 2011, and forecasts are provided through 2018.

Key Questions This Study Will Answer

• Is the market growing, how long will it continue to grow, and at what rate?
• What are the drivers and restraints influencing the market?
• Which are high-growth segments and why?
• Which Mega Trends are affecting the market and when?
• What are the strategic recommendations that will help the market players grow?